Lesaffre Human Care to introduce new Active Pharmaceutical Ingredients at CPhI Worldwide

Lesaffre Human Care is excited to present its latest yeast-derived active pharmaceutical ingredients (API) to the pharma community at CPhI Worldwide. Thanks to extremely high-quality standards and a specific manufacturing process complying with pharmaceutical specifications, all of these ingredients are API-certified and can therefore be used in medical devices or in over-the-counter and prescription drugs.

The company’s latest development is a range of complementary innovative yeast ingredients designed to offer women natural day-to-day support in managing vaginal infections. With over 75% of women worldwide experiencing at least one episode of vulvovaginal candidiasis in their life, Lesaffre Human Care’s dedicated VAGINACTIV range provides comprehensive and soothing solutions to protect the vaginal epithelium and accelerate C. albicans clearance.

One of the solutions provided, Pharma VAGINACTIV LocalWomen's health is a natural unique ingredient specifically designed to help fight pathogenic yeast C.albicans. Due to its 100 % mechanical action, it is compliant with the new European Regulation for medical devices that will be effective in 2020.

At the show, the company will also be showcasing  Pharma S. boulardii (Saccharomyces cerevisiae var. boulardii CNCM I-4978). Saccharomyces cerevisiae var. boulardii is one of the most documented probiotic in the world and can be considered as a safe, reliable and natural way to help people of all ages maintain a balanced intestinal flora for optimal gut comfort.

Another Active Pharmaceutical Ingredient that will be featured is Pure SAMe, S-Adenosyl-L-Methionine for oral and injectable forms. Pure molecule from fermentation, Pure SAMe is specifically intended for use in pharmaceutical products. S-Adenosyl-L-Methionine has proven efficacy in helping enhance emotional wellbeing, support joint function and mobility as well as maintain a healthy liver.

Read the Press Release in English.